953 related articles for article (PubMed ID: 11210070)
1. A comparative study utilizing open flap debridement with and without enamel matrix derivative in the treatment of periodontal intrabony defects: a 12-month re-entry study.
Froum SJ; Weinberg MA; Rosenberg E; Tarnow D
J Periodontol; 2001 Jan; 72(1):25-34. PubMed ID: 11210070
[TBL] [Abstract][Full Text] [Related]
2. Clinical comparison of an enamel matrix derivative used alone or in combination with a bovine-derived xenograft for the treatment of periodontal osseous defects in humans.
Velasquez-Plata D; Scheyer ET; Mellonig JT
J Periodontol; 2002 Apr; 73(4):433-40. PubMed ID: 11990445
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of demineralized freeze-dried bone allograft and enamel matrix derivative versus enamel matrix derivative alone for the treatment of periodontal osseous defects in humans.
Gurinsky BS; Mills MP; Mellonig JT
J Periodontol; 2004 Oct; 75(10):1309-18. PubMed ID: 15562907
[TBL] [Abstract][Full Text] [Related]
4. A clinical comparison of a bovine-derived xenograft used alone and in combination with enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Scheyer ET; Velasquez-Plata D; Brunsvold MA; Lasho DJ; Mellonig JT
J Periodontol; 2002 Apr; 73(4):423-32. PubMed ID: 11990444
[TBL] [Abstract][Full Text] [Related]
5. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of demineralized freeze-dried bone allograft with and without enamel matrix derivative for the treatment of periodontal osseous defects in humans.
Hoidal MJ; Grimard BA; Mills MP; Schoolfield JD; Mellonig JT; Mealey BL
J Periodontol; 2008 Dec; 79(12):2273-80. PubMed ID: 19053917
[TBL] [Abstract][Full Text] [Related]
7. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
8. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of periodontal intrabony defects with calcium sulfate implant and barrier versus collagen barrier or open flap debridement alone: a 12-month randomized controlled clinical trial.
Paolantonio M; Perinetti G; Dolci M; Perfetti G; Tetè S; Sammartino G; Femminella B; Graziani F
J Periodontol; 2008 Oct; 79(10):1886-93. PubMed ID: 18834243
[TBL] [Abstract][Full Text] [Related]
10. Effects of pretreatment clinical parameters on bioactive glass implantation in intrabony periodontal defects.
Park JS; Suh JJ; Choi SH; Moon IS; Cho KS; Kim CK; Chai JK
J Periodontol; 2001 Jun; 72(6):730-40. PubMed ID: 11453234
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial.
Peres MF; Ribeiro ED; Casarin RC; Ruiz KG; Junior FH; Sallum EA; Casati MZ
J Clin Periodontol; 2013 Mar; 40(3):252-9. PubMed ID: 23379539
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a bioactive glass alloplast in treating periodontal intrabony defects.
Ong MM; Eber RM; Korsnes MI; MacNeil RL; Glickman GN; Shyr Y; Wang HL
J Periodontol; 1998 Dec; 69(12):1346-54. PubMed ID: 9926764
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a biphasic calcium composite grafting material in the treatment of human periodontal intrabony defects: a 12-month randomized controlled clinical trial.
Stein JM; Fickl S; Yekta SS; Hoischen U; Ocklenburg C; Smeets R
J Periodontol; 2009 Nov; 80(11):1774-82. PubMed ID: 19905932
[TBL] [Abstract][Full Text] [Related]
14. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
Batista EL; Novaes AB; Simonpietri JJ; Batista FC
J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
[TBL] [Abstract][Full Text] [Related]
15. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of an enamel matrix protein derivative combined with a bioactive glass for the treatment of intrabony periodontal defects in humans.
Sculean A; Barbé G; Chiantella GC; Arweiler NB; Berakdar M; Brecx M
J Periodontol; 2002 Apr; 73(4):401-8. PubMed ID: 11990441
[TBL] [Abstract][Full Text] [Related]
18. Effect of EDTA root conditioning on the healing of intrabony defects treated with an enamel matrix protein derivative.
Sculean A; Berakdar M; Willershausen B; Arweiler NB; Becker J; Schwarz F
J Periodontol; 2006 Jul; 77(7):1167-72. PubMed ID: 16805678
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of an enamel matrix protein derivative combined with either a natural bone mineral or beta-tricalcium phosphate.
Döri F; Arweiler N; Gera I; Sculean A
J Periodontol; 2005 Dec; 76(12):2236-43. PubMed ID: 16332235
[TBL] [Abstract][Full Text] [Related]
20. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
